Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Advanced Glycation End Products as a Potential Target for Restructuring the Ovarian Cancer Microenvironment: A Pilot Study

Title: Advanced Glycation End Products as a Potential Target for Restructuring the Ovarian Cancer Microenvironment: A Pilot Study
Authors: Elizabeth I. Harper; Michael D. Siroky; Tyvette S. Hilliard; Gena M. Dominique; Catherine Hammond; Yueying Liu; Jing Yang; Veronica B. Hubble; Danica J. Walsh; Roberta J. Melander; Christian Melander; Matthew J. Ravosa; M. Sharon Stack
Source: International Journal of Molecular Sciences, Vol 24, Iss 12, p 9804 (2023)
Publisher Information: MDPI AG
Publication Year: 2023
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: ovarian cancer; advanced glycation end product (AGE); collagen; omentum; microenvironment; AGE breakers; Biology (General); QH301-705.5; Chemistry; QD1-999
Description: Ovarian cancer is the sixth leading cause of cancer-related death in women, and both occurrence and mortality are increased in women over the age of 60. There are documented age-related changes in the ovarian cancer microenvironment that have been shown to create a permissive metastatic niche, including the formation of advanced glycation end products, or AGEs, that form crosslinks between collagen molecules. Small molecules that disrupt AGEs, known as AGE breakers, have been examined in other diseases, but their efficacy in ovarian cancer has not been evaluated. The goal of this pilot study is to target age-related changes in the tumor microenvironment with the long-term aim of improving response to therapy in older patients. Here, we show that AGE breakers have the potential to change the omental collagen structure and modulate the peritoneal immune landscape, suggesting a potential use for AGE breakers in the treatment of ovarian cancer.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.mdpi.com/1422-0067/24/12/9804; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067; https://doaj.org/article/26896f93f6584929b2ab99099e3acf7a
DOI: 10.3390/ijms24129804
Availability: https://doi.org/10.3390/ijms24129804; https://doaj.org/article/26896f93f6584929b2ab99099e3acf7a
Accession Number: edsbas.E01E6978
Database: BASE